Molecular Biomarkers in Cancer

Molecular cancer biomarkers are any measurable molecular indicator of risk of cancer, occurrence of cancer, or patient outcome. They may include somatic genetic variants, epigenetic signatures, transcriptional changes and proteomic signatures. These indicators are based on biomolecules, such as nucleic acids and proteins, that can be detected in samples obtained from tissues through tumor biopsy or, more easily and non-invasively, from blood, saliva.

  • Biomolecules
  • Detection technologies
  • Clinical applications of biomarkers
  • Diagnosis and prognosis of Cancer
  • Cancer Medicine

Related Conference of Molecular Biomarkers in Cancer

November 19-20, 2026

44th World Cancer Conference

Dubai, UAE
November 23-24, 2026

8th International Conference on Women Oncology

Miami, USA
November 23-24, 2026

7th Cancer Diagnostics & Treatment Conference

Miami, USA
November 24-25, 2026

6th International Conference on Oncology and Cancer

Paris, France
December 03-04, 2026

10th Global Meeting on Oncology and Radiology

Madrid, Spain
December 08-09, 2026

27th World Congress on Cancer Summit

Paris, France
December 08-09, 2026

14th Euro Breast Cancer and Therapeutics

Paris, France
February 15-16, 2027

5th World Congress on Oral Cancer

Singapore City, Singapore
April 15-16, 2027

12th World Conference on Breast and Cervical Cancer

Amsterdam, Netherlands
April 26-27, 2027

26th World Congress on Cancer and Diagnostics

Barcelona, Spain
April 27-28, 2027

37th Experts Meet On Cancer Research & Therapy

Paris, France
May 05-06, 2027

7th World Congress on Breast Cancer

Berlin, Germany
May 05-06, 2027

23rd International Conference on Cancer Research

Berlin, Germany

Molecular Biomarkers in Cancer Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in